This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bacus, J. W. Articles by Lippman, S. M. Search for Related Content PubMed PubMed Citation Articles by Bacus, J. W. Articles by Lippman, S. M.

Image Morphometric Nuclear Grading of Intraepithelial Neoplastic Lesions with Applications to Cancer Chemoprevention Trials¹

Bacus Laboratories, Inc., Lombard, Illinois 60148 [J. W. B., J. V. B.]; Chemoprevention Program, Division of Cancer Prevention, National Cancer Institute, NIH, Bethesda, Maryland 20892 [C. W. B., G. J. K.]; and University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4095 [M. F., V. K., S. M. L.]

A new image morphometric method of nuclear grading is described and assessed in the context of the evaluation of histological samples from ductal carcinoma in situ of the breast and cervical intraepithelial neoplasia. The method results in a continuous scaled variable, or nuclear grading scale, expressed in SD units from measured normal nuclei from breast or cervix. For a given histological preinvasive neoplastic lesion, the mean nuclear grade of measured nuclei was shown to be analogous to the histopathological nuclear grade of the same lesion assigned subjectively by the pathologist. In a chemoprevention trial of the effect of difluoromethylornithine given for 1 month to subjects with cervical intraepithelial neoplasia grade 3, pathologists could see no difference in 14 histological sections taken before and after difluoromethylornithine treatment. However, the image morphometric method detected a systematic effect of lowered mean nuclear grade and a decrease in the variability of nuclear grade expression. Twelve of 14 samples showed a lower posttreatment mean nuclear grade (P < 0.05), and 13 of the 14 samples showed a decrease in the SD of their nuclear grade distributions (P < 0.01). This study demonstrates the use of image morphometric nuclear grading in a chemoprevention setting. It may be very useful in supplementing the pathologist’s histopathological grading by providing objective, quantitative assessments.

This article has been cited by other articles:

				M. Lakshman, L. Xu, V. Ananthanarayanan, J. Cooper, C. H. Takimoto, I. Helenowski, J. C. Pelling, and R. C. Bergan Dietary Genistein Inhibits Metastasis of Human Prostate Cancer in Mice Cancer Res., March 15, 2008; 68(6): 2024 - 2032. [Abstract] [Full Text] [PDF]

				J. D. Debes, T. J. Sebo, H. V. Heemers, B. R. Kipp, D. A. L. Haugen, C. M. Lohse, and D. J. Tindall p300 Modulates Nuclear Morphology in Prostate Cancer Cancer Res., February 1, 2005; 65(3): 708 - 712. [Abstract] [Full Text] [PDF]

				A.-T. Vlastos, L. A. West, E. N. Atkinson, I. Boiko, A. Malpica, W. K. Hong, and M. Follen Results of a Phase II Double-Blinded Randomized Clinical Trial of Difluoromethylornithine for Cervical Intraepithelial Neoplasia Grades 2 to 3 Clin. Cancer Res., January 1, 2005; 11(1): 390 - 396. [Abstract] [Full Text] [PDF]

				C. J. Fabian, B. F. Kimler, J. Anderson, O. W. Tawfik, M. S. Mayo, W. E. Burak Jr., J. A. O'Shaughnessy, K. S. Albain, D. M. Hyams, G. T. Budd, et al. Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator Clin. Cancer Res., August 15, 2004; 10(16): 5403 - 5417. [Abstract] [Full Text] [PDF]

				P. Wolfe, J. Murphy, J. McGinley, Z. Zhu, W. Jiang, E. B. Gottschall, and H. J. Thompson Using Nuclear Morphometry to Discriminate the Tumorigenic Potential of Cells: A Comparison of Statistical Methods Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 976 - 988. [Abstract] [Full Text] [PDF]

				B. Gary, R. Azuero, G. S. Mohanty, W. C. Bell, I.-E. A. Eltoum, and S. A. Abdulkadir Interaction of Nkx3.1 and p27kip1 in Prostate Tumor Initiation Am. J. Pathol., May 1, 2004; 164(5): 1607 - 1614. [Abstract] [Full Text] [PDF]

				R. D. Alvarez, M. G. Conner, H. Weiss, P. M. Klug, S. Niwas, U. Manne, J. Bacus, V. Kagan, K. C. Sexton, C. J. Grubbs, et al. The Efficacy of 9-Cis-Retinoic Acid (Aliretinoin) as a Chemopreventive Agent for Cervical Dysplasia: Results of a Randomized Double-Blind Clinical Trial Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 114 - 119. [Abstract] [Full Text] [PDF]

				C. J. Fabian, B. F. Kimler, D. A. Brady, M. S. Mayo, C. H. J. Chang, J. A. Ferraro, C. M. Zalles, A. L. Stanton, S. Masood, W. E. Grizzle, et al. A Phase II Breast Cancer Chemoprevention Trial of Oral {alpha}-Difluoromethylornithine: Breast Tissue, Imaging, and Serum and Urine Biomarkers Clin. Cancer Res., October 1, 2002; 8(10): 3105 - 3117. [Abstract] [Full Text] [PDF]

				A. Hoque, N. Sneige, A. A. Sahin, D. G. Menter, J. W. Bacus, G. N. Hortobagyi, and S. M. Lippman HER-2/neu Gene Amplification in Ductal Carcinoma In Situ of the Breast Cancer Epidemiol. Biomarkers Prev., June 1, 2002; 11(6): 587 - 590. [Abstract] [Full Text] [PDF]

				J. A. O'Shaughnessy, G. J. Kelloff, G. B. Gordon, A. J. Dannenberg, W. K. Hong, C. J. Fabian, C. C. Sigman, M. M. Bertagnolli, S. P. Stratton, S. Lam, et al. Treatment and Prevention of Intraepithelial Neoplasia: An Important Target for Accelerated New Agent Development : Recommendations of the American Association for Cancer Research Task Force on the Treatment and Prevention of Intraepithelial Neoplasia Clin. Cancer Res., February 1, 2002; 8(2): 314 - 346. [Abstract] [Full Text] [PDF]

				A. Hoque, S. M. Lippman, I. V. Boiko, E. N. Atkinson, N. Sneige, A. Sahin, D. M. Weber, S. Risin, M. D. Lagios, R. Schwarting, et al. Quantitative Nuclear Morphometry by Image Analysis for Prediction of Recurrence of Ductal Carcinoma in Situ of the Breast Cancer Epidemiol. Biomarkers Prev., March 1, 2001; 10(3): 249 - 259. [Abstract] [Full Text]

				A. Hoque, D. G. Menter, A. A. Sahin, N. Sneige, and S. M. Lippman No Increased Ki67 Expression in Ductal Carcinoma in Situ Associated with Invasive Breast Cancer Cancer Epidemiol. Biomarkers Prev., February 1, 2001; 10(2): 153 - 154. [Full Text]

				C. W. Boone, G. D. Stoner, J. V. Bacus, V. Kagan, M. A. Morse, G. J. Kelloff, and J. W. Bacus Chemoprevention with Theaflavins of Rat Esophageal Intraepithelial Neoplasia Quantitatively Monitored by Image Tile Analysis Cancer Epidemiol. Biomarkers Prev., November 1, 2000; 9(11): 1149 - 1154. [Abstract] [Full Text]

				W. K. Hong, M. R. Spitz, and S. M. Lippman Cancer Chemoprevention in the 21st Century: Genetics, Risk Modeling, and Molecular Targets J. Clin. Oncol., November 1, 2000; 18(90001): 9s - 18. [Full Text] [PDF]

				C. W. Boone, G. D. Stoner, J. V. Bacus, V. Kagan, M. A. Morse, G. J. Kelloff, and J. W. Bacus Quantitative Grading of Rat Esophageal Carcinogenesis Using Computer-assisted Image Tile Analysis Cancer Epidemiol. Biomarkers Prev., May 1, 2000; 9(5): 495 - 500. [Abstract] [Full Text]